Search results
Poop has been an easy target for microbiome research, but voyages into the small intestine shed new...
The Conversation via Yahoo News· 20 hours agoMuch of the small intestine microbiome remains an undiscovered frontier. Stefano Madrigali/Moment...
Research Analysts Offer Predictions for Zura Bio Limited’s FY2024 Earnings (NASDAQ:ZURA)
ETF DAILY NEWS· 7 hours agoZura Bio Limited (NASDAQ:ZURA – Free Report) – Research analysts at Cantor Fitzgerald issued their FY2024 earnings per share (EPS) estimates for shares of Zura Bio in a < ...
Decoding Elastic NV (ESTC): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 3 hours agoElastic NV showcases robust revenue growth and a transition to profitability in fiscal 2024. Subscription services remain the dominant revenue stream,...
Tesla Stock Will Ride Higher on Musk’s Pay Raise. Plus, GM, Warner Bros., and More.
Barrons.com· 9 hours agoRESEARCH REPORTS These reports, excerpted and edited by Barron’s, were issued recently by investment...
GLJ Research cuts Daqo shares target, highlights financial health risks By Investing.com
Investing.com· 19 hours agoOn Friday, GLJ Research adjusted their outlook on Daqo New Energy Corp (NYSE:DQ) shares, a leading...
FY2026 EPS Estimates for Pool Co. Decreased by Zacks Research (NASDAQ:POOL)
ETF DAILY NEWS· 6 hours agoPool Co. (NASDAQ:POOL – Free Report) – Analysts at Zacks Research lowered their FY2026 EPS estimates...
A major disinformation research team's future is uncertain after political attacks
WAMC Northeast Public Radio· 15 hours agoThe Stanford Internet Observatory, a prominent research group at Stanford University studying how...
Q2 2025 EPS Estimates for Foot Locker, Inc. (NYSE:FL) Decreased by Analyst
ETF DAILY NEWS· 5 hours agoFoot Locker, Inc. (NYSE:FL – Free Report) – Analysts at Zacks Research reduced their Q2 2025 earnings per share estimates for Foot Locker in a research ...
Hexcel Co. to Post FY2025 Earnings of $2.84 Per Share, Zacks Research Forecasts (NYSE:HXL)
ETF DAILY NEWS· 6 hours agoHexcel Co. (NYSE:HXL – Free Report) – Equities research analysts at Zacks Research upped their FY2025 earnings estimates for shares of Hexcel in a note ...
Nebula Research & Development LLC Takes $926,000 Position in Revance Therapeutics, Inc....
ETF DAILY NEWS· 3 days agoNebula Research & Development LLC purchased a new stake in Revance Therapeutics, Inc. (NASDAQ:RVNC – Free Report) during the 4th quarter, according to the company in its most ...